Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Raymond F. Schinazi Christina Gavegnano Catherine Montero Alberto Bosque Vicente Planelles |
| Publication date | January 13, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |